The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of simple blood biomarkers of systemic inflammation for metastatic renal cell carcinoma (mRCC) patients who undergo cytoreductive nephrectomy (CNx).
 
Jigi Moudgil-Joshi
No Relationships to Disclose
 
Mark Stares
No Relationships to Disclose
 
Alex Laird
No Relationships to Disclose
 
Steve Leung
No Relationships to Disclose
 
Jahangeer Malik
No Relationships to Disclose
 
Aravindhan Sundaramurthy
No Relationships to Disclose
 
Stefan N. Symeonides
Consulting or Advisory Role - Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ellipses Pharma (Inst); EUSA Pharma (Inst); MedAnnex (Inst); MSD (Inst); Pfizer/EMD Serono (Inst); Vaccitech (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); EUSA Pharma (Inst); Novartis (Inst)
Research Funding - BiolineRx (Inst); BioNTech (Inst); Boston Pharmaceuticals (Inst); Merck Sharp & Dohme (Inst); Nouscom (Inst); Nucana (Inst); Sapience Therapeutics (Inst); Sierra Oncology (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen